SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 177.30 |
| Enterprise Value ($M) | 508.48 |
| Book Value ($M) | -24.98 |
| Book Value / Share | -0.43 |
| Price / Book | -7.10 |
| NCAV ($M) | -185.35 |
| NCAV / Share | -3.20 |
| Price / NCAV | -0.96 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.21 |
| Return on Equity (ROE) | -2.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.09 |
| Current Ratio | 4.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 217.90 |
| Assets | 378.27 |
| Liabilities | 403.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -164.53 |
| Net Income | -117.81 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 74.73 |
| Cash from Investing | 27.45 |
| Cash from Financing | -106.08 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ingalls & Snyder Llc | 7.00 | 7.25 | |
| 13G/A | Demopulos Gregory A MD | 8.80 | 2.74 | |
| 13G | Vanguard Group Inc | 5.04 | 12.36 | |
| 13G | BlackRock Inc. | 6.80 | 249.15 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,322 | 142,470 | 11.46 | |
| 67,026 | 265,792 | 25.22 | |
| 51,142 | 95,985 | 53.28 | |
| 32,304 | 76,589 | 42.18 | |
| 47,891 | 105,789 | 45.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NTLA – Intellia Therapeutics, Inc. | OCS – Oculis Holding AG |
| OCUL – Ocular Therapeutix, Inc. | PAHC – Phibro Animal Health Corporation |
| PROC – Procaps Group S.A. |